Menopause is More Than a Hot Flash

Hot flashes, mood swings, vaginal changes. Those are what most women expect with menopause. But bladder function disruption? Most doctors don’t tell women about that part.

Hot flashes, mood changes, sleep disruption, and vaginal dryness or discomfort are what most women are told to expect with menopause, and what most conversations focus on. What isn’t discussed as often are changes in bladder function.

Urinary symptoms are common but under-discussed, and many women are not counseled on them despite their prevalence and impact on quality of life. An estimated 60% of women in the U.S. will experience bladder health issues or lower urinary tract symptoms (LUTS) as they age, yet awareness is low.¹

Symptoms don’t come out of nowhere in “old age.” In the beginning, during perimenopause, it’s probably subtle: more frequent urination, feeling a sudden urgency, waking up at night to go to the bathroom, leaking with a cough or workout, or getting more frequent urinary tract infections (UTIs). It can be dismissed as normal aging or treated as an isolated issue, but they’re connected to the same hormonal shifts that affect the vaginal tissues and pelvic floor.

A System in Transition

Menopause is driven by a decline in estrogen that influences the health of tissues throughout the body. The vagina, urethra, and bladder all have a high concentration of estrogen receptors and are directly affected by hormonal changes.

As estrogen levels decline, genitourinary tissues undergo structural changes. The lining of the vagina becomes thinner, less elastic, and less lubricated. The tissues of the urethra and bladder also lose some of their strength and resilience, collagen production decreases, and blood flow is reduced. Unlike hot flashes, which tend to improve over time, urinary changes persist and sometimes progress if they’re not addressed.

Packaged under the umbrella of genitourinary syndrome of menopause (GSM), symptoms and severity vary from person to person. Some women only notice subtle changes without any disruption to daily life. Others develop more persistent overactive bladder-type symptoms that have a greater impact on quality of life: sudden urgency, reduced ability to delay voiding, and increased daytime and nighttime frequency, sometimes with leakage occurring before reaching the bathroom.

Another pattern women experience is stress incontinence. Leakage with coughing, laughing, exercise, or lifting could either start happening or become worse, reflecting weakening of pelvic floor muscles and the structures that support the urethra. Some women experience a mixed bag, where both urgency and stress components overlap, making the symptom pattern less predictable and more limiting, functionally and socially. At the severe end of the spectrum, urgency, frequency, nocturia, and leakage combine with vaginal dryness and irritation, and can progress into a more advanced urogenital tissue atrophy.

Dropping estrogen levels also changes vaginal pH and microbiome composition. A change in vaginal flora does not cause overt incontinence, but it does contribute to bacterial vulnerability and recurrent UTIs.

Menopause is traditionally simplified into a short list of symptoms. But what’s actually happening is a broader biological transition that affects tissue integrity, microbial balance, and cellular function across interconnected systems throughout the body, from the vagina to the heart and the bladder to the brain. To boot, symptom expression does not correlate with hormonal decline alone – baseline health, pelvic floor strength, prior childbirth, body weight, and genetics all influence how menopause presents itself.

Now What?

Knowing that your symptoms can be attributed to biological changes, there are also targeted ways to address them. Options range from traditional to novel and from conservative to invasive, depending on how much symptoms affect your day-to-day life.

Pelvic floor physical therapy and muscle training, including Kegels, sit on the least invasive end of the spectrum. When done correctly and consistently, strengthening the pelvic muscles can actually improve both leakage and urgency. One study found that 92% of participants noticed a distinct difference in their stress and urge incontinence symptoms.² Important point: if done improperly or by women with a tight pelvic floor, traditional Kegels can make some symptoms worse. It’s best to consult with a physical therapist or specialist for proper guidance.

Regenerative and energy-based therapies are also gaining traction and delivering impressive results. Through different mechanisms, platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and radiofrequency-based treatment modalities stimulate collagen production and promote blood flow, which brings micronutrients to the area. Function is restored by improving the health of the tissue itself, rather than superficially masking symptoms as some over-the-counter (OTC) lubricants can do.

Because so much of this can be hormone-driven, local vaginal estrogen does wonders as a directly targeted treatment. Topical application works at the tissue level to restore the integrity of the vaginal and urethral lining. By rebalancing the vaginal environment, women tend to experience fewer symptoms of urgency and frequency, improved control, and a lower risk of recurrent urinary tract infections by more than 75% in some cases.³ It’s one of the most commonly used treatments for vaginal atrophy and GSM-related symptoms overall.

Used for broader menopausal symptoms, systemic hormone replacement therapy (HRT) has had mixed results for specific use in voiding dysfunction, and large studies show it is actually associated with an increased risk of urinary incontinence. Evidence from a major cohort and a separate meta-analysis indicates that both oral and transdermal systemic estrogen (alone or with progesterone) tend to worsen incontinence. Currently, there is no evidence to suggest a meaningful role for systemic HRT in treating lower urinary tract symptoms.⁴

The American Urological Association takes a flexible, patient-centered approach, stating both vaginal and systemic hormone therapies are supported for managing GSM and that treatment is unique to the individual. As such, treatments should be guided by effectiveness, safety, patient preference, access, and ability to use the therapy consistently, though the strongest research and overall clinical experience is currently behind vaginal estrogen.⁵

If there are other biological reasons at work, and hormone- and exercise-based therapies aren’t quite enough, there are other therapies women can consider. Also, different treatments can be used in tandem to address various aspects of what’s going on. The symptoms are unique, and the remedy likely will be, too.

Medications can help calm an overactive bladder; biofeedback and electrical stimulation can improve muscle coordination; and devices like pessaries can support pelvic structures. For more persistent cases, your urologist may discuss neuromodulation, bladder Botox, or surgical procedures, such as urethral slings.

The Longer You Wait…

Don’t be afraid to explore your options. For some women, all they need is a little boost from regular use of vaginal estrogen. For others, it may be a combination of therapies that does the trick. There isn’t a single fix, because these symptoms manifest differently in every woman. They’re also not something you just have to put up with.

When you start noticing these changes, it’s safe to say they aren’t going to get any better, and it’s worth a chat to see what you can do to slow or halt the progression. Let’s go through what’s actually driving your symptoms and what options make sense for you. Get in touch with Dr. Taghechian at Aayla and start feeling like yourself again.

Resources:

1. Tillman, E. W. (2025, September 25). Menopausal Status and Hormones Impact Bladder Health – Menopause: A Peer-to-Peer Approach. Medpagetoday.com. https://www.medpagetoday.com/resource-centers/menopause-peer-peer-approach/menopausal-status-and-hormones-impact-bladder-health/6013.
2. Șerbănescu, L., Mirea, S., Ionescu, P., Petrica, L. A., Iorga, I. C., Surdu, M., Surdu, T. V., & Rotar, V. (2025). Involuntary Urine Loss in Menopause—A Narrative Review. Journal of Clinical Medicine, 14(21). https://doi.org/10.3390/jcm14217664.
3. Cichowski, S. B. (2023, November). UTIs After Menopause: Why They’re Common and What to Do About Them. Www.acog.org. https://www.acog.org/womens-health/experts-and-stories/the-latest/utis-after-menopause-why-theyre-common-and-what-to-do-about-them.
4. Robinson, D. (2024). Oestrogens and lower urinary tract dysfunction chronicling a lifetime of research. Continence, 12. https://doi.org/10.1016/j.cont.2024.101720.
5. Kaufman, M. R., Ackerman, A. L., Amin, K. A., Coffey, M., Danan, E., Faubion, S. S., Hardart, A., Goldstein, I., Ippolito, G. M., Northington , G. M., Powell, C. R., Rubin, R. S., Westney, O. L., Wilson, T. S., & Lee, U. J. (2025, September 1). Genitourinary Syndrome of Menopause: AUA/FUFU/AUGS Guideline (2025) – American Urological Association. Auanet.org. https://www.auajournals.org/doi/10.1097/JU.0000000000004589.